NEW YORK (GenomeWeb) – Venture development company TechAccel said this week that it has invested in agricultural biotechnology company Epicrop Technologies. Epicrop is developing an epigenetic technology to improve crop yields. The investment is part of Epicrop's extended Series A round, which raised a total of $3.2 million. Additional investments were made by North Forty Ventures, Nelnet, Speedway Properties, and Allen & Company. TechAccel and Epicrop are also planning to create a joint venture to pursue new target crops using Epicrop's technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.